What Algorithmic Biologics does
Founded in 2021, Algorithmic Biologics operates in Health Tech industry. Originally focused on enhancing DNA synthesis and sequencing processes, the company has evolved to incorporate machine learning algorithms into its platforms for more precise data interpretation. Algorithmic Biologics announced the launch of a new tool aimed at improving diagnostic accuracy for genetic disorders. The company also expanded its offerings to include cloud-based solutions that cater to research institutions across India. Competing with companies such as Pandorum Technologies and String Bio.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Algorithmic Biologics yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.